Özden GÖKDEMİR, Halil DALKIRAN, Ilgın ŞİMŞİR YILDIRIM, Füsun SAYGILI, MEHTAP KARTAL

Halsizlikle gelen 19 yaşında erkek hastada adrenal yetmezlik

Adrenal yetmezlik oldukça enderdir ve %70-90ı otoimmün adrenalitis sonucu meydana gelir. Geri kalan olgular ise diğer enfeksiyonlar, kanser metastazı, adrenal hemoraji / infarkt ya da ilaç etkisine bağlı gelişir. Primer adrenal yetmezlik Addison hastalığı olarak da bilinir ve adrenal korteksin hastalığıdır. Adrenal yetmezlik genellikle 10-15 yaşlarında başlar. Bu yazıda, yorgunluk ve halsizlik yakınmaları ile başvuran ve adrenal yetmezlik tanısı alan genç erkek bir olgu sunulmaktadır. Bu gibi semptomlarla başvuran genç hastalarda adrenal yetmezlik akılda tutulmalıdır. Ender görülen fakat tanı aldığında tedavi edilebilen bu hastalığın yönetiminde erken tanı ve tedavi hayat kurtarıcıdır.

Adrenal insufficiency in a 19-year-old male patient admitted with fatigue

Adrenal insufficiency is quite rare and 70-90% of cases develop as a result of autoimmune adrenalitis. The rest may be the result of infections, metastasis, adrenal haemorrhage / infarct or adverse effects of drugs. Primary adrenal insufficiency, also known as Addison' s disease, is a disease of adrenal cortex. Adrenal insufficiency generally starts around 10 to 15 years of age. In this report, a young male patient admitted with fatigue and weakness and diagnosed as adrenal insufficiency is presented. Adrenal insufficiency should be kept in mind in patients presented with these symptoms. Early diagnosis and treatment are lifesaving managements in this rare, but curable disease.

___

1. Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. The Lancet. 2014;383(9935):2152-67. 2. Løvås K, Husebye ES. High prevalence and increasing incidence of Addison's disease in western Norway. Clin Endocrinol 2002;56(6):787-91. 3. Laway BA, Khan I, Shah BA, Choh NA, Bhat MA, Shah ZA. Pattern of adrenal morphology and function in pulmonary tuberculosis: response to treatment with antitubercular therapy. Clin Endocrinol 2013;79(3):321-5. 4. Erichsen MM, Løvås K, Skinningsrud B, et al. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: Observations from a Norwegian registry. J Clin Endocrinol Metab 2009;94(12):4882-90. 5. Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G. Premature mortality in patients with Addisons disease: A population-based study. J Clin Endocrinol Metab 2006;91(12):4849-53. 6. Gylling M, Tuomi T, Björses P, et al. ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal Dystrophy. J Clin Endocrinol Metab 2000;85(12):4434-40. 7. Adrenal ve Gonadal Hastalıklar Çalışma Grubu TEvMD. Adrenal ve Gonadal Hastalıklar Kılavuzu 2011. [cited 27 Ağustos 2014]. Available from: http://www.temd.org.tr/files/pdf/HPA_Kilavuzu.pdf 8. Perry R, Kecha O, Paquette J, Huot C, Van Vliet G, Deal C. Primary adrenal insufficiency in children: Twenty years experience at the Sainte-Justine Hospital, Montreal. J Clin Endocrinol Metab 2005;90(6):3243-50. 9. Arlt W. The approach to the adult with newly diagnosed adrenal insufficiency. J Clin Endocrinol Metab 2009;94(4):1059-67. 10. El Fassi D, Nielsen G. Hyperkalemia: A clue to the diagnosis of adrenal insufficiency. Circulation 2013;128(24):2620.